Ledge Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.41M Sell
8,373
-189
-2% -$51.5K 0.94% 33
2023
Q3
$2.3M Buy
8,562
+978
+13% +$244K 1.03% 29
2023
Q2
$1.68M Sell
7,584
-950
-11% -$220K 0.8% 38
2023
Q1
$2.06M Buy
8,534
+587
+7% +$144K 0.98% 34
2022
Q4
$2.09M Buy
7,947
+1,516
+24% +$406K 0.95% 33
2022
Q3
$1.45M Sell
6,431
-1,103
-15% -$267K 0.89% 36
2022
Q2
$1.83M Buy
7,534
+628
+9% +$154K 1.13% 28
2022
Q1
$1.67M Buy
+6,906
New +$1.59M 1.04% 30

Other funds holding AMGN

Ledge Wealth Management's AMGN Position: Q4 2023 in Review

Ledge Wealth Management reduced its Amgen (AMGN) stake by 2.2% in Q4 2023, selling an estimated $51.5K and leaving 8,373 shares worth $2.41M. The position accounts for 0.94% of the portfolio, ranked #33.

Ledge Wealth Management first reported a position in AMGN in Q1 2022 and has held it in 8 quarters since. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Ledge Wealth Management held 8,373 shares of Amgen worth $2.41M as of Q4 2023.
  • Ledge Wealth Management sold 189 Amgen shares in Q4 2023, an estimated $51.5K.
  • Amgen made up 0.94% of Ledge Wealth Management's portfolio in Q4 2023, its #33 holding.
  • Ledge Wealth Management first reported a position in Amgen in Q1 2022 and has held it in 8 quarters since.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Ledge Wealth Management's 13F filing for Q4 2023, filed 24 Jan 2024.